Abstract

The UK NICE has released guidance on the use of erythropoietin receptor agonists for anaemia induced by cancer treatment.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call